Cosmopolitan Industries (PVT.) Limited, a Corporate Director of the Company, has completed its buying of 180,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 30.12.2025.

(Q2 Un-audited): EPS was Tk. 14.30 for October-December 2025 as against Tk. 15.09 for October-December 2024; EPS was Tk. 28.59 for July-December 2025 as against Tk. 27.82 for July-December 2024. NOCFPS was Tk. 110.22 for July-December 2025 as against Tk. 158.78 for July-December 2024. NAV per share was Tk. 287.10 as on December 31, 2025 and Tk. 278.51 as on June 30, 2025.

(Q2 Un-audited): Consolidated EPS was Tk. 0.37 for October-December 2025 as against Tk. 0.52 for October-December 2024; Consolidated EPS was Tk. 0.59 for July-December 2025 as against Tk. 0.73 for July-December 2024. Consolidated NOCFPS was Tk. 1.59 for July-December 2025 as against Tk. 3.47 for July-December 2024. Consolidated NAV per share was Tk. 51.56 as on December 31, 2025 and Tk. 51.51 as on June 30, 2025.

The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase securities of Ambee Pharmaceuticals PLC with effect from today i.e., January 28, 2026 as per rule 11(8) of Bangladesh Securities and Exchange Commission (Margin) Rules, 2025.

The Company has been placed in 'Z' category from existing 'A' category with effect from today i.e., January 28, 2026 as per provision 1(e) of BSEC Directive No. BSEC/CMRRCD/2009-193/77, dated May 20, 2024 regarding non-disbursement of the approved dividend within the stipulated time frame.

(Q2 Un-audited): EPS was Tk. (0.46) for October-December 2025 as against Tk. 0.24 for October-December 2024; EPS was Tk. (1.23) for July-December 2025 as against Tk. 0.36 for July-December 2024. NOCFPS was Tk. (1.44) for July-December 2025 as against Tk. 1.47 for July-December 2024. NAV per share was Tk. 136.39 as on December 31, 2025 and Tk. 137.61 as on June 30, 2025.

(Q2 Un-audited): EPS was Tk. 0.14 for October-December 2025 as against Tk. 0.35 for October-December 2024; EPS was Tk. 0.83 for July-December 2025 as against Tk. 0.60 for July-December 2024. NOCFPS was Tk. 1.95 for July-December 2025 as against Tk. 1.50 for July-December 2024. NAV per share was Tk. 48.72 as on December 31, 2025 and Tk. 48.39 as on June 30, 2025.

(Continuation news of AGNISYSL): Reason for deviation: In the current period, EPS declined as a result of elevated operating expenses linked to the launch of a new business segment. NOCFPS fell during this period, driven chiefly by a reduction in suppliers' payables and rising operating expenses. The decrease in payables stems from settling debts carried over from the prior period, which consequently lowered cash flows generated from operating activities. (end)

(Q2 Un-audited): EPS was Tk. 0.23 for October-December 2025 as against Tk. 0.60 for October-December 2024; EPS was Tk. 0.57 for July-December 2025 as against Tk. 0.92 for July-December 2024. NOCFPS was Tk. 0.87 for July-December 2025 as against Tk. 1.06 for July-December 2024. NAV per share was Tk. 17.27 as on December 31, 2025 and Tk. 16.95 as on June 30, 2025. (cont.)

A team of Dhaka Stock Exchange PLC. (DSE) inspected the factory premises of Dominage Steel Building Systems Limited at Ashulia, Savar, and Polash, Narsingdi on November 03 and 04, 2025, respectively, to assess the company's current operational status. During the inspection, it was observed that the Ashulia, Savar unit of the company was operational, while the Polash, Narsingdi unit of the company was found closed.